Growth Metrics

QuidelOrtho (QDEL) EPS (Weighted Average and Diluted) (2021 - 2024)

QuidelOrtho (QDEL) has disclosed EPS (Weighted Average and Diluted) for 4 consecutive years, with -$25.5 as the latest value for Q1 2024.

  • Quarterly EPS (Weighted Average and Diluted) fell 3593.15% to -$25.5 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was -$25.39 through Dec 2024, down 154.63% year-over-year, with the annual reading at -$30.54 for FY2024, 20260.0% down from the prior year.
  • EPS (Weighted Average and Diluted) hit -$25.5 in Q1 2024 for QuidelOrtho, down from -$9.71 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $11.31 in Q2 2022 to a low of -$25.5 in Q1 2024.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$1.65 across 4 years, with a median of $0.28 in 2022.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): fell 20.0% in 2022 and later crashed 5968.75% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at $5.08 in 2021, then plummeted by 94.49% to $0.28 in 2022, then tumbled by 3567.86% to -$9.71 in 2023, then plummeted by 162.62% to -$25.5 in 2024.
  • Business Quant data shows EPS (Weighted Average and Diluted) for QDEL at -$25.5 in Q1 2024, -$9.71 in Q4 2023, and -$0.19 in Q4 2023.